Research Topics
| S Lori BrownSummaryAffiliation: Food and Drug Administration Country: USA Publications
| Collaborators
|
Detail Information
Publications
Breast implant surveillance reports to the U.S. Food and Drug Administration: maternal-child health problemsS Lori Brown
Division of Postmarket Surveillance, Office of Surveillance and Biometrics, Center for Devices and Radiological Health Food and Drug Administration, Seattle District Office, Bothell, WA 98021 4421, USA
J Long Term Eff Med Implants 16:281-90. 2006..An additional 3.5% of reports (n=12) detailed a congenital anomaly believed by the reporter to be caused by breast implants...
Silicone gel breast implant adverse event reports to the Food and Drug Administration, 1984-1995S L Brown
Office of Surveillance and Biometrics, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD 20850, USA
Public Health Rep 113:535-43. 1998....- Local anesthetic infusion pump systems adverse events reported to the Food and Drug AdministrationS Lori Brown
Division of Postmarket Surveillance, Office of Surveillance and Biometrics, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Maryland, USA
Anesthesiology 100:1305-7. 2004 - Breast implant adverse events during mammography: reports to the Food and Drug AdministrationS Lori Brown
Division of Postmarket Surveillance, Office of Surveillance and Biometrics, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Maryland 20850, USA
J Womens Health (Larchmt) 13:371-8; discussion 379-80. 2004..To characterize reports of adverse events occurring during mammography to women with breast implants submitted to the Food and Drug Administration (FDA)... - An association of silicone-gel breast implant rupture and fibromyalgiaS Lori Brown
US Food and Drug Administration, Epidemiology Branch, Center for Devices and Radiological Health, HFZ 541, 1350 Piccard Drive, Rockville, MD 20850, USA
Curr Rheumatol Rep 4:293-8. 2002..These findings should also be important for regulatory decision making on silicone-gel breast implants... - Epidemiology of silicone-gel breast implantsS Lori Brown
Office of Surveillance and Biometrics, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD 20850, USA
Epidemiology 13:S34-9. 2002.... - Role of serology in the diagnosis of Lyme diseaseS L Brown
Division of Postmarket Surveillance, Food and Drug Administration, Center for Devices and Radiological Health, Rockville, MD, USA
JAMA 282:62-6. 1999..A negative result on the Western blot or ELISA indicates that there is no serologic evidence of infection by B burgdorferi at the time the sample was drawn... - Adjustable silicone gastric banding adverse events reported to the Food and Drug AdministrationS Lori Brown
Division of Postmarket Surveillance, Office of Surveillance and Biometrics, Center for Devices and Radiologic Health, Food and Drug Administration, 1350 Piccard Dr, HFZ 541 Rockville MD 20850, USA
J Long Term Eff Med Implants 13:509-17. 2003..The loose connection may cause pain and the device no longer performs as intended when there is a leak... - Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug AdministrationS Lori Brown
Center for Biologics Evaluation and Research, FDA, Rockville, Maryland 20852, USA
Arthritis Rheum 46:3151-8. 2002.... - Replacement surgery and silicone gel breast implant rupture: self-report by women after mammoplastyS Lori Brown
Epidemiology Branch, Division of Postmarket Surveillance, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Maryland 20850, USA
J Womens Health Gend Based Med 11:255-64. 2002..Women considering silicone gel breast implants should be informed of the risk of additional surgeries and of the potential risk of breast implant rupture... - Breast pump adverse events: reports to the food and drug administrationS Lori Brown
Division of Postmarket Surveillance, Epidemiology Branch, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, Maryland 20850, USA
J Hum Lact 21:169-74. 2005..Breast pump adverse events are likely underreported to the FDA. Reporting adverse events is important for improving the design and manufacture of breast pumps and subsequently decreasing adverse events... - Surgical stapler-associated fatalities and adverse events reported to the Food and Drug AdministrationS Lori Brown
Epidemiology Branch, Division of Postmarket Surveillance, Office of Surveillance and Biometrics, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD 20850, USA
J Am Coll Surg 199:374-81. 2004..It is important for health-care providers to report adverse events to manufacturers so that they may work to improve the design of these devices and reduce use errors that contribute to the events... - Allergic reaction to platinum in silicone breast implantsSambasiva R Arepalli
Division of General, Restorative, and Neurological Devices, Office of Device Evaluation, Food and Drug Administration, Rockville, Maryland 20850, USA
J Long Term Eff Med Implants 12:299-306. 2002.... - Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanerceptJong-Hoon Lee
Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, FDA, 1401 Rockville Pike, Rockville, MD 20852-1448, USA
Arthritis Rheum 46:2565-70. 2002..Histoplasmosis should be considered early in the evaluation of patients who reside in HC-endemic areas in whom infectious complications develop during treatment with infliximab or etanercept... - MR imaging of extracapsular silicone from breast implants: diagnostic pitfallsWendie A Berg
Department of Radiology, University of Maryland, University Imaging Center, 419 W. Redwood St, Ste. 110, Baltimore, MD 21201, USA
AJR Am J Roentgenol 178:465-72. 2002..Water-suppressed inversion-recovery T2-weighted images are often needed to identify extracapsular silicone. Distinction of the bulge in the fibrous capsule from herniation through the capsule remains problematic... - Medical device epidemiology and surveillance: patient safety is the bottom lineS Lori Brown
Expert Rev Med Devices 1:1-2. 2004